SCTX Scribe Therapeutics, Inc.
Healthcare · Market cap: $309.7M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $71.3M | $0 |
| 2026-Q4 | $0 | $0 |
Bought$71.3M7 buy days
Sold$00 sell days
Net insider flow+$71.3Mnet buying · 5 years
Latest trade2026-07-28Aghazadeh Behzad
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-07-28 | Buy | Aghazadeh Behzad | Director | 7,905 | $18.25 | $144.3K | 1 |
| 2026-07-27 | Buy | GORDON CARL L | Director | 1,000,000 | $15.00 | $15.0M | 1 |
| 2026-07-27 | Buy | ORBIMED ADVISORS LLC | Director | 1,000,000 | $15.00 | $15.0M | 1 |
| 2026-07-27 | Buy | Andreessen Marc L | 10% owner | 333,333 | $15.00 | $5.0M | 1 |
| 2026-07-24 | Buy | Aghazadeh Behzad | Director | 2,383,333 | $15.15 | $36.1M | 2 |
| 2026-07-23 | Buy | Lucas Svetlana | Other C-suite | 3,000 | $15.00 | $45.0K | 1 |
| 2026-07-23 | Buy | Parrot David | CFO | 1,333 | $15.00 | $20.0K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Aghazadeh Behzad | Director | $36.3M | $0 | 2026-07-28 |
| GORDON CARL L | Director | $15.0M | $0 | 2026-07-27 |
| ORBIMED ADVISORS LLC | Director | $15.0M | $0 | 2026-07-27 |
| Andreessen Marc L | 10% owner | $5.0M | $0 | 2026-07-27 |
| Lucas Svetlana | Other C-suite | $45.0K | $0 | 2026-07-23 |
| Parrot David | CFO | $20.0K | $0 | 2026-07-23 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2026-07-23 → 2026-07-28 | 6 | $71.3M | 47 | +55.6% (+59.8% raw) | -15.8% (-11.6% raw) | – | active |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.